X-COR Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- X-COR Therapeutics's estimated annual revenue is currently $627.5k per year.
- X-COR Therapeutics's estimated revenue per employee is $125,500
- X-COR Therapeutics's total funding is $2.8M.
Employee Data
- X-COR Therapeutics has 5 Employees.
- X-COR Therapeutics grew their employee count by -17% last year.
X-COR Therapeutics's People
| Name | Title | Email/Phone |
|---|
X-COR Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $11M | 44 | 13% | N/A | N/A |
#2 | $11M | 44 | 29% | N/A | N/A |
#3 | $4.3M | 17 | 0% | N/A | N/A |
#4 | $3.8M | 15 | -29% | N/A | N/A |
#5 | $5630M | 9122 | -11% | $450M | N/A |
#6 | $4.3M | 17 | 0% | N/A | N/A |
#7 | $4M | 16 | -72% | $23.5M | N/A |
#8 | $44.4M | 177 | 9% | N/A | N/A |
#9 | $45.7M | 182 | 0% | N/A | N/A |
#10 | $15M | 79 | 8% | $105.2M | N/A |
What Is X-COR Therapeutics?
X-COR Therapeutics is a Boston based medical device company creating the first commercially available CO2 removal device that uses ultra-low-blood flows for a cheaper, safer, and more accessible treatment for acute respiratory failure.
keywords:N/A
$2.8M
Total Funding
5
Number of Employees
$627.5k
Revenue (est)
-17%
Employee Growth %
N/A
Valuation
N/A
Accelerator
X-COR Therapeutics News
2022-04-20 - Inflammasome activation in infected macrophages drives ...
... in lungs of infected MISTRG6-hACE2 in response to therapeutics. ... based on Pearson's product-moment correlation coefficient cor(x,...
Other Companies in Allston
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.4M | 6 | 20% | N/A |
#2 | $1.2M | 14 | -52% | N/A |
#3 | $3.1M | 20 | -5% | $0.009M |
#4 | $3.5M | 21 | 0% | N/A |
#5 | $1.7M | 22 | 10% | $37M |